IX

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

After 15 Years, First New Recombinant Coagulation Factor IX (Rixubis) Gains Orphan Drug Approval

By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago